Marcus Wolfgang Kurt Egermann

Marcus Wolfgang Kurt Egermann

Current Position:

Assistant Medical Director of the Clinic for Orthopedic and Trauma Surgery

Clinical Focus:

  • joint replacement at hip and knee including joint preserving surgery


  • consultant for orthopaedic and trauma surgery, specialist in orthopaedic surgery and pediatric orthopedics

Scientific Focus:

  • fracture healing in osteoporosis, bone healing in spinal cord injury, osteonecrosis


  • since 02/2013: medical head of technical orthopedics (additional position)
  • since 10/2010: Assistant Medical Director of the Clinic for Orthopedic and Trauma Surgery
  • since 09/2009: consultant, Clinic for Orthopedic and Trauma Surgery, Heidelberg University


  • since 03/2006: Clinic for Orthopedic and Trauma Surgery, Heidelberg University Hospital
  • 2004 – 2006: Clinic for Trauma Surgery, UniversityHospital Zürich, Director Prof. Dr. O. Trentz
  • 2001 – 2004: Research Fellow and assistant research group leader, AO Research Institut Davos Director Prof. E. Schneider (fellowship with Prof. Iain Clarke, Melbourne;  Prof. Chris Evans, Boston, USA)
  • 2000 – 2001: Clinic for Orthopedics, Heidelberg University Hospital


  • 1993-1995: Medical School, Free University Berlin
  • 1995-2000: Medical School, Ruprecht-Karls-University Heidelberg


  • Master of Health Business Administration (MHBA), USMLE I und II


  • faculty member of medical doctorates at Heidelberg University, head of clinical research at clinic for orthopedic and trauma surgery


  • 2014


  • 2015

Pepke W, Lehner B, Bekeredjian-Ding I, Egermann M.
Haematogenous infection of a total knee arthroplasty with Klebsiella pneumoniae. BMJ Case Rep. 2013;Apr 15

Wagner-Ecker M, Voltz P, Egermann M, Richter W.
The collagen component of biological bone graft substitutes promotes ectopic bone formation by human mesenchymal stem cells.
Acta Biomater. 2013 Jul;9(7):7298-307

Engel M, Castrillon-Oberndorfer G, Hoffmann J, Egermann M, Freudlsperger C, Thiele OC.
Cranial vault remodeling in microcephalicosteodysplastic primordial dwarfism type II and craniosynostosis.
J CraniofacSurg. 2012 Sep;23(5):1407-9

Oheim R, Beil FT, Barvencik F, Egermann M, Amling M, Clarke IJ, Pogoda P.
Targeting the lateral but not the third ventricle induces bone loss in ewe: an experimental approach to generate an improved large animal model of osteoporosis.
J Trauma Acute Care Surg. 2012 Mar;72(3):720

Egermann M, Gerhardt C, Barth A, Maestroni GJ, Schneider E, Alini M.
Pinealectomy affects bone mineral density and structure--an experimental study in sheep.
BMC MusculoskeletDisord. 2011 Nov 24;12:271.

Janicki P, Boeuf S, Steck E, Egermann M, Kasten P, Richter W.
Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells.
EurCell Mater. 2011 Jun 20;21:488-507

Mischnik A, Zimmermann S, Bekeredjian-Ding I, Egermann M.
Relapse of posttraumatic osteo-myelitis due to Clostridium celerecrescens. Infection.
2011 Oct;39(5):491-4

Kloth JK, Egermann M, Weber MA.
Symptomatic bilateral soft tissue tumor of the breast wall. Radiologe.
2011 May;51(5):388

Mueller TL, Wirth AJ, van Lenthe GH, Goldhahn J, Schense J, Jamieson V, Messmer P, Uebelhart D, Weishaupt D, Egermann M, Müller R.
Mechanical stability in a human radius fracture treated with a novel tissue-engineered bone substitute: a noninvasive, longitudinal assessment using high-resolution pQCT in combination with finite element analysis.
J Tissue Eng Regen Med. 2011 May;5(5):415-20

Radler C, Egermann M, Riedl K, Ganger R, Grill F.
Interobserver reliability of radiographic measurements of contralateral feet of pediatric patients with unilateral clubfoot.
J Bone Joint Surg Am. 2010 Oct 20;92(14):2427

Egermann M, Heil P, Tami A, Janicki P, Ito K, Hofstetter W, Richards PJ.
Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis.
J Orthop Res. 2010 Jun;28(6):798-804.

Egermann M, Suda A, Moghaddam A, Kasten P.
Behandlung von Knochendefekten mit Stammzellen. Innovatives Therapiekonzept für Patienten mit Hüftkopfnekrose und Pseudarthrose.
MMW Fortschritte der Medizin. Originalien Nr. II/2009: 111-114.

Egermann M, Döderlein L, Schläger E, Müller S, Braatz F.
Autologous capping during resection arthroplasty of the hip in patients with cerebral palsy.
J Bone Joint Surg Br. 2009 Aug;91(8):1007-12.

Egermann M, Kasten P, Thomsen M.
Myoelectric hand prostheses in very young children.
IntOrthop. 2009 Aug;33(4):1101-5

Dickhut A, Pelttari K, Janicki P, Wagner W, Eckstein V, Egermann M, Richter W.
Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage.
J Cell Physiol. 2009 Apr;219(1):219

Kasten P, Beyen I, Egermann M, Suda AJ, Moghaddam AA, Zimmermann G, Luginbühl R.
Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro.
Eur Cell Mater. 2008 Oct 23;16:47-55

Egermann M, Goldhahn J, Holz R, Schneider E, Lill CA.
A sheep model for fracture treatment in osteoporosis: benefits of the model versus animal welfare.
Lab Anim. 2008 Oct;42(4):453-64

Diaz Sanchez-Bustamante C, Kelm JM, Egermann M, Djonov V, Fussenegger M.
Ectopic expression of delta FBJ murine osteosarcoma viral oncogene homolog B mediates transdifferentiation of adipose-like spheroids into osteo-like microtissues.
Tissue Eng Part A. 2008 Aug;14(8):1377-94

Sigrist IM, Gerhardt C, Alini M, Schneider E, Egermann M.
The long-term effects of ovariectomy on bone metabolism in sheep.
J.BoneMiner.Metab 2007;25:28-35.

Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA, Vrahas MS, Bouxsein ML, Evans CH.:
Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects.
Gene Ther. 2007 Jul;14(13):1039-44

Pogoda P, Egermann M, Schnell JC, Priemel M, Schilling AF, Alini M et al.
Leptin inhibits bone formation not only in rodents, but also in sheep.
J.BoneMiner.Res. 2006;21:1591

Egermann M, Lill CA, Griesbeck K, Evans CH, Robbins PD, Schneider E et al.
Effect of BMP-2 gene transfer on bone healing in sheep.
Gene Ther. 2006;13:1290-9.

Egermann M, Baltzer AW, Adamaszek S, Evans C, Robbins P, Schneider E et al.
Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep.
Hum.GeneTher. 2006;17:507-17.

Arens D, Sigrist I, Alini M, Schawalder P, Schneider E, Egermann M.
Seasonalchanges in bonemetabolism in sheep.
Vet.J. 2006. Nov 30

Handschin AE, Egermann M, Wedler V, Trentz O, Hemmi S, and Trentz OA. A
Comparative Analysis of Phenotype Expression in Human Osteoblasts From Heterotopic Ossification and Normal Bone.
Langenbecks Arch Surg 2006;391(4):376-82

Handschin AE, Egermann M, Trentz O, Wanner GA, Kock HJ, Zund G, Trentz OA.
Cbfa-1 (Runx-2) and osteocalcin expression by human osteoblasts in heparin osteoporosis in vitro.
Clin Appl Thromb Hemost. 2006 Oct;12(4):465-72

Egermann M, Thomsen M.
Myoelektrische Prothesen bei Kindern im Kindergartenalter. Analyse der Akzeptanz und erste Erfahrungen.
Orthopäde 2003;32:164-9.

Egermann M, Brocai D, Lill CA, Schmitt H.
Analysis of injuries in long-distance triathletes.
Int.J.Sports Med. 2003;24:271-6.

Weiss C, Egermann M, Bartsch P.
Exercise-induced activation of coagulation in subjects with activated protein C resistance.
Blood Coagul Fibrinolysis. 2004 Jun;15(4):317-21

Weiss C, Egermann M, Weiss T, Bartsch P.
Exercise-induced activation of coagulation in thrombophilia.
J ThrombHaemost. 2003 Jun;1(6):1312-3

Go back